Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Romanian consumers are becoming increasingly pessimistic about the country's economic and political outlook while continuing to prioritise spending and aggressively seek value, according to the latest Consumer Sentiment Survey by Boston Consulting Group (BCG).
The TechAngels Board has appointed Ana Maria Andronic as President for a mandate lasting until next year's internal elections.
Romanian entrepreneur Iulian Stanciu has announced the sale of his stake in eMAG Group to Prosus, 17 years after taking over the company and 14 years after signing the partnership with Naspers (Prosus).
Romania's National Commission for Strategy and Prognosis (CNSP) has cut its 2026 economic growth forecast by 0.9 percentage points to just 0.1%, down from the previous 1% projection, citing current macroeconomic conditions.
Enexus, a renewable energy development and construction company, entered 2026 with 210 MW under active construction across Romania, while securing an additional 195 MW pipeline with an estimated value of approximately €150 million.